Results of an open label study of zerit, videx, crixivan and norvir in protease inhibitor naive HIV-infected patients

被引：0
|
作者：
Anderson, R [1 ]
Williamson, D [1 ]
Corey, N [1 ]
Shultz, E [1 ]
Lenzi, D [1 ]
机构：
[1] Anderson Clin Res, Pittsburgh, PA USA
来源：
AIDS | 2000年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P78
引用
收藏
页码：S39 / S39
页数：1
相关论文
共 50 条
  • [31] Predictors of long-term response to protease inhibitor therapy in a cohort of HIV-infected patients
    Casado, JL
    Perez-Elías, MJ
    Antela, A
    Sabido, R
    Martí-Belda, P
    Dronda, F
    Blazquez, J
    Quereda, C
    AIDS, 1998, 12 (11) : F131 - F135
  • [32] Percentage of adherence correlates with the risk of protease inhibitor (PI) treatment failure in HIV-infected patients
    Casado, JL
    Sabido, R
    Perez-Elías, MJ
    Antela, A
    Oliva, J
    Dronda, F
    Mejía, B
    Fortún, J
    ANTIVIRAL THERAPY, 1999, 4 (03) : 157 - 161
  • [33] Acute pancreatitis in HIV-infected patients: Are etiologies changing since the introduction of protease inhibitor therapy?
    Bush, ZM
    Kosmiski, LA
    PANCREAS, 2003, 27 (01) : E1 - E5
  • [34] Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patients
    Zeldin, RK
    Petruschke, RA
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (01) : 4 - 9
  • [35] Limitations of a simplification antiretroviral strategy for HIV-infected patients with decreasing adherence to a protease inhibitor regimen
    Moya, J.
    Casado, J. L.
    Aranzabal, L.
    Moreno, A.
    Antela, A.
    Dronda, F.
    Perez-Elías, M. J.
    Marin, A.
    Moreno, S.
    HIV CLINICAL TRIALS, 2006, 7 (04): : 210 - 214
  • [36] Protease inhibitor-based HAART, HDL, and CHD-risk in HIV-infected patients
    Asztalos, BF
    Schaefer, EJ
    Horvath, KV
    Cox, CE
    Skinner, S
    Gerrior, J
    Gorbach, SL
    Wanke, C
    ATHEROSCLEROSIS, 2006, 184 (01) : 72 - 77
  • [37] TRIMETHOPRIM-SULFAMETHOXAZOLE DESENSITIZATION IN HIV-INFECTED PATIENTS - AN OPEN STUDY
    BACHMEYER, C
    SALMON, D
    GUERIN, C
    BARRE, C
    HAZEBROUCQ, G
    SICARD, D
    SERENI, D
    AIDS, 1995, 9 (03) : 299 - 300
  • [38] Outcome of HIV-infected patients started on a protease-inhibitor (PI) containing regimen:: results at 5 years of the APROCO-COPILOTE Cohort Study
    Chêne, G
    Leport, C
    Spire, B
    Lewden, C
    Pierret, J
    Peytavin, G
    Brum-Vezinet, F
    Le Moing, V
    Salamon, R
    Raffi, F
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 24 : S120 - S120
  • [39] A prospective cohort study on the risk for lipodystrophy in HIV-infected patients treated with protease inhibitor-containing regimens.
    Martínez, E
    Mocroft, A
    García-Viejo, MA
    Pérez-Cuevas, JB
    Bianco, JL
    Mallolas, J
    Bianchi, L
    Conget, I
    Gatell, JM
    AIDS, 2000, 14 : S55 - S55
  • [40] Frequency and patterns of protease gene resistance mutations in HIV-infected patients treated with lopinavir/ritonavir as their first protease inhibitor
    Barber, Tristan J.
    Harrison, Linda
    Asboe, David
    Williams, Ian
    Kirk, Stuart
    Gilson, Richard
    Bansi, Loveleen
    Pillay, Deenan
    Dunn, David
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (04) : 995 - 1000
12345